Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and ...

Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

The Trump administration has reportedly disrupted over 100 clinical trials. Science News spoke to researchers about the impacts on four of them.

Key Takeaways A pill to treat obesity caused liver injury in a clinical trialPfizer said it will stop developing the drug, called danuglipron, as a result Other alternatives to injectable obesity ...

The company said it would stop studying the experimental drug, danuglipron, after a participant in one of its clinical trials experienced a possible drug-induced liver injury that ended once the ...

Pfizer is ending the development of its potential once-daily pill treatment for obesity before venturing into the biggest and most expensive level of clinical testing. The drugmaker said Tuesday ...

A hormone-free male birth control pill is undergoing clinical testing for the first time ever. The drug, called YCT-529, has ...

The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a possible drug-induced liver injury that ended once the person stopped ...

The company said it would stop studying the experimental drug, danuglipron, after a participant in one of its clinical trials experienced a possible drug-induced liver injury that ended once the ...